Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in J Surg Oncol

Retrieve available abstracts of 78 articles:
HTML format
Text format



Single Articles


    August 2015
  1. SMITHERS BM, Hughes MC, Beesley VL, Barbour AP, et al
    Prospective study of patterns of surgical management in adults with primary cutaneous melanoma at high risk of spread, in Queensland, Australia.
    J Surg Oncol. 2015 Aug 27. doi: 10.1002/jso.24013.
    PubMed     Text format     Abstract available


  2. SABEL MS, Lee J, Wang A, Lao C, et al
    Morphomics predicts response to ipilimumab in patients with stage IV melanoma.
    J Surg Oncol. 2015 Aug 7. doi: 10.1002/jso.24003.
    PubMed     Text format     Abstract available


    July 2015
  3. BERTOLLI E, Bevilacqua JL, Molina AS, de Macedo MP, et al
    Popliteal sentinel lymph node involvement in melanoma patients.
    J Surg Oncol. 2015 Jul 31. doi: 10.1002/jso.23978.
    PubMed     Text format     Abstract available


    June 2015
  4. DOUSSOT A, Nardin C, Takaki H, Litchman TD, et al
    Liver resection and ablation for metastatic melanoma: A single center experience.
    J Surg Oncol. 2015 Jun 12. doi: 10.1002/jso.23929.
    PubMed     Text format     Abstract available


    May 2015
  5. FANG Y, Chen X, Bai Q, Qin C, et al
    IL-9 inhibits HTB-72 melanoma cell growth through upregulation of p21 and TRAIL.
    J Surg Oncol. 2015 May 18. doi: 10.1002/jso.23930.
    PubMed     Text format     Abstract available


    February 2015
  6. HU Y, Shah P, Stukenborg GJ, Slingluff CL Jr, et al
    Utility of sentinel lymph node biopsy for solitary dermal melanomas.
    J Surg Oncol. 2015 Feb 24. doi: 10.1002/jso.23890.
    PubMed     Text format     Abstract available


  7. RAWLANI R, Rawlani V, Qureshi HA, Kim JY, et al
    Reducing margins of wide local excision in head and neck melanoma for function and cosmesis: 5-year local recurrence-free survival.
    J Surg Oncol. 2015 Feb 24. doi: 10.1002/jso.23886.
    PubMed     Text format     Abstract available


  8. BAKER JJ, Meyers MO, Deal AM, Frank JF, et al
    Prognostic significance of tumor mitotic rate in T2 melanoma staged with sentinel lymphadenectomy.
    J Surg Oncol. 2015 Feb 8. doi: 10.1002/jso.23880.
    PubMed     Text format     Abstract available


    November 2014
  9. LOOK HONG NJ, Petrella T, Chan K
    Cost-effectiveness analysis of staging strategies in patients with regionally metastatic melanoma.
    J Surg Oncol. 2014 Nov 24. doi: 10.1002/jso.23833.
    PubMed     Text format     Abstract available


    August 2014
  10. CLOYD JM, Wapnir IL, Read BM, Swetter S, et al
    Indocyanine green and fluorescence lymphangiography for sentinel lymph node identification in cutaneous melanoma.
    J Surg Oncol. 2014 Aug 13. doi: 10.1002/jso.23745.
    PubMed     Text format     Abstract available


    July 2014
  11. BYERS BA, Temple-Oberle CF, Hurdle V, McKinnon JG, et al
    Treatment of in-transit melanoma with intra-lesional interleukin-2: A systematic review.
    J Surg Oncol. 2014 Jul 3. doi: 10.1002/jso.23702.
    PubMed     Text format     Abstract available


    June 2014
  12. KAISER S, Vassell R, Pinckney RG, Holmes TE, et al
    Clinical impact of biopsy method on the quality of surgical management in melanoma.
    J Surg Oncol. 2014;109:775-9.
    PubMed     Text format     Abstract available


  13. FRANKEL TL, Bamboat ZM, Ariyan C, Coit D, et al
    Predicting the development of brain metastases in patients with local/regional melanoma.
    J Surg Oncol. 2014;109:770-4.
    PubMed     Text format     Abstract available


    May 2014
  14. GILL K, Ariyan C, Wang X, Brady MS, et al
    CD30-positive lymphoproliferative disorders arising after regional therapy for recurrent melanoma: A report of two cases and analysis of CD30 expression.
    J Surg Oncol. 2014 May 30. doi: 10.1002/jso.23636.
    PubMed     Text format     Abstract available


    April 2014
  15. STEINMAN J, Ariyan C, Rafferty B, Brady MS, et al
    Factors associated with response, survival, and limb salvage in patients undergoing isolated limb infusion.
    J Surg Oncol. 2014;109:405-9.
    PubMed     Text format     Abstract available


    March 2014
  16. COVENTRY BJ, Kroon HM, Giles MH, Henderson M, et al
    Australian multi-center experience outside of the Sydney Melanoma Unit of isolated limb infusion chemotherapy for melanoma.
    J Surg Oncol. 2014 Mar 15. doi: 10.1002/jso.23590.
    PubMed     Text format     Abstract available


  17. LIDSKY ME, Speicher PJ, Jiang B, Tsutsui M, et al
    Isolated limb infusion as a model to test new agents to treat metastatic melanoma.
    J Surg Oncol. 2014;109:357-65.
    PubMed     Text format     Abstract available


  18. KROON HM, Huismans AM, Kam PC, Thompson JF, et al
    Isolated limb infusion with melphalan and actinomycin D for melanoma: A systematic review.
    J Surg Oncol. 2014;109:348-51.
    PubMed     Text format     Abstract available


  19. DAMIAN DL, Saw RP, Thompson JF
    Topical immunotherapy with diphencyprone for in transit and cutaneously metastatic melanoma.
    J Surg Oncol. 2014;109:308-13.
    PubMed     Text format     Abstract available


  20. ROSS MI
    Intralesional therapy with PV-10 (Rose Bengal) for in-transit melanoma.
    J Surg Oncol. 2014;109:314-9.
    PubMed     Text format     Abstract available


  21. CAMPANA LG, Testori A, Mozzillo N, Rossi CR, et al
    Treatment of metastatic melanoma with electrochemotherapy.
    J Surg Oncol. 2014;109:301-7.
    PubMed     Text format     Abstract available


  22. SOLARI N, Spagnolo F, Ponte E, Quaglia A, et al
    Electrochemotherapy for the management of cutaneous and subcutaneous metastasis: a series of 39 patients treated with palliative intent.
    J Surg Oncol. 2014;109:270-4.
    PubMed     Text format     Abstract available


  23. KROON HM, Huismans A, Waugh RC, Kam PC, et al
    Isolated limb infusion: technical aspects.
    J Surg Oncol. 2014;109:352-6.
    PubMed     Text format     Abstract available


    February 2014
  24. LODH S, Maher R, Guminski A
    Intra-arterial infusion and chemo-embolization for melanoma liver metastases.
    J Surg Oncol. 2014 Feb 5. doi: 10.1002/jso.23551.
    PubMed     Text format     Abstract available


    January 2014
  25. TEMPLE-OBERLE CF, Byers BA, Hurdle V, Fyfe A, et al
    Intra-lesional interleukin-2 therapy for in transit melanoma.
    J Surg Oncol. 2014 Jan 22. doi: 10.1002/jso.23556.
    PubMed     Text format     Abstract available


  26. NIEWEG OE, Kroon BB
    Isolated limb perfusion with melphalan for melanoma.
    J Surg Oncol. 2014 Jan 14. doi: 10.1002/jso.23558.
    PubMed     Text format     Abstract available


  27. THOMPSON JF
    Local and regional therapies for melanoma: Many arrows in the quiver.
    J Surg Oncol. 2014 Jan 14. doi: 10.1002/jso.23559.
    PubMed     Text format    


  28. HOEKSTRA HJ, Veerman K, van Ginkel RJ
    Isolated limb perfusion for in-transit melanoma metastases: Melphalan or TNF-melphalan perfusion?
    J Surg Oncol. 2014 Jan 9. doi: 10.1002/jso.23552.
    PubMed     Text format     Abstract available


    December 2013
  29. BARSKY M, Cherkassky L, Vezeridis M, Miner TJ, et al
    The role of preoperative positron emission tomography/computed tomography (PET/CT) in patients with high-risk melanoma.
    J Surg Oncol. 2013 Dec 30. doi: 10.1002/jso.23549.
    PubMed     Text format     Abstract available


  30. SHASHANK A, Shehata M, Morris DL, Thompson JF, et al
    Radiofrequency ablation in metastatic melanoma.
    J Surg Oncol. 2013 Dec 30. doi: 10.1002/jso.23548.
    PubMed     Text format     Abstract available


  31. GOMEZ D, Wetherill C, Cheong J, Jones L, et al
    The Liverpool uveal melanoma liver metastases pathway: Outcome following liver resection.
    J Surg Oncol. 2013 Dec 19. doi: 10.1002/jso.23535.
    PubMed     Text format     Abstract available


  32. HERSEY P, Gallagher S
    Intralesional immunotherapy for melanoma.
    J Surg Oncol. 2013 Dec 3. doi: 10.1002/jso.23494.
    PubMed     Text format     Abstract available


    November 2013
  33. FOGARTY GB, Hong A
    Radiation therapy for advanced and metastatic melanoma.
    J Surg Oncol. 2013 Nov 27. doi: 10.1002/jso.23509.
    PubMed     Text format     Abstract available


  34. FORSTER MR , Rashid OM, Perez MC, Choi J, et al
    Chemosaturation with percutaneous hepatic perfusion for unresectable metastatic melanoma or sarcoma to the liver: A single institution experience.
    J Surg Oncol. 2013 Nov 19. doi: 10.1002/jso.23501.
    PubMed     Text format     Abstract available


  35. JOHN HE , Mahaffey PJ
    Laser ablation and cryotherapy of melanoma metastases.
    J Surg Oncol. 2013 Nov 19. doi: 10.1002/jso.23488.
    PubMed     Text format     Abstract available


    October 2013
  36. YAMAMOTO M , Zager JS
    Isolated hepatic perfusion for metastatic melanoma.
    J Surg Oncol. 2013 Oct 25. doi: 10.1002/jso.23474.
    PubMed     Text format     Abstract available


  37. KELLER DS , Thomay AA, Gaughan J, Olszanski A, et al
    Outcomes in patients with mucosal melanomas.
    J Surg Oncol. 2013 Oct 16. doi: 10.1002/jso.23445.
    PubMed     Text format     Abstract available


    June 2013
  38. RYU SW , Saw R, Scolyer RA, Crawford M, et al
    Liver resection for metastatic melanoma: Equivalent survival for cutaneous and ocular primaries.
    J Surg Oncol. 2013 Jun 27. doi: 10.1002/jso.23361.
    PubMed     Text format     Abstract available


    December 2012
  39. GZIRI MM , Han SN, Amant F
    Use of general anesthesia and sentinel node procedure during pregnancy.
    J Surg Oncol. 2012;106:1008.
    PubMed     Text format    


    October 2012
  40. RYCHETNIK L , McCaffery K, Morton RL, Thompson JF, et al
    Follow-up of early stage melanoma: Specialist clinician perspectives on the functions of follow-up and implications for extending follow-up intervals.
    J Surg Oncol. 2012 Oct 22. doi: 10.1002/jso.23278.
    PubMed     Text format     Abstract available


    July 2012
  41. FUJISAWA Y , Nakamura Y, Kawachi Y, Otsuka F, et al
    Indocyanine green fluorescence-navigated sentinel node biopsy showed higher sensitivity than the radioisotope or blue dye method, which may help to reduce false-negative cases in skin cancer.
    J Surg Oncol. 2012;106:41-5.
    PubMed     Text format     Abstract available


    June 2012
  42. TEWARI M , Choudhary S, Sherigar V, Kumar M, et al
    Melanoma of the lacrimal gland: A case report.
    J Surg Oncol. 2012 Jun 11. doi: 10.1002/jso.23193.
    PubMed     Text format    


  43. MARTINEZ SR , Shah DR, Maverakis E, Yang AD, et al
    Geographic variation in utilization of sentinel lymph node biopsy for intermediate thickness cutaneous melanoma.
    J Surg Oncol. 2012 Jun 4. doi: 10.1002/jso.23169.
    PubMed     Text format     Abstract available


  44. PAPADIA F , Basso V, Patuzzo R, Maurichi A, et al
    Isolated limb perfusion with the tumor-targeting human monoclonal antibody-cytokine fusion protein L19-TNF plus melphalan and mild hyperthermia in patients with locally advanced extremity melanoma.
    J Surg Oncol. 2012 Jun 4. doi: 10.1002/jso.23168.
    PubMed     Text format     Abstract available


    April 2012
  45. SABEL MS
    Sentinel lymph node biopsy for thin melanoma-con.
    J Surg Oncol. 2012 Apr 4. doi: 10.1002/jso.23001.
    PubMed     Text format    


    March 2012
  46. KOSHENKOV VP , Shulkin D, Bustami R, Chevinsky AH, et al
    Role of sentinel lymphadenectomy in thin cutaneous melanomas with positive deep margins on initial biopsy.
    J Surg Oncol. 2012 Mar 15. doi: 10.1002/jso.23093.
    PubMed     Text format     Abstract available


    February 2012
  47. BROER N , Buonocore S, Goldberg C, Truini C, et al
    A proposal for the timing of management of patients with melanoma presenting during pregnancy.
    J Surg Oncol. 2012 Feb 13. doi: 10.1002/jso.23035.
    PubMed     Text format     Abstract available


    November 2011
  48. NAKAMURA Y , Fujisawa Y, Maruyama H, Furuta J, et al
    Intraoperative mapping with isosulfan blue of lymphatic leakage during inguinal lymph node dissection (ILND) for skin cancer for the prevention of postoperative lymphocele.
    J Surg Oncol. 2011;104:657-60.
    PubMed     Text format     Abstract available


    October 2011
  49. PAPANASTASSIOU ID , Jain S, Baaj AA, Eleraky M, et al
    Vertebrectomy and expandable cage placement via a one-stage, one-position anterolateral retroperitoneal approach in L5 tumors.
    J Surg Oncol. 2011;104:552-8.
    PubMed     Text format     Abstract available


    September 2011
  50. BEITSCH P , Huber T
    Community melanoma research: From start up to follow up.
    J Surg Oncol. 2011;104:447-51.
    PubMed     Text format     Abstract available


  51. SONDAK VK , Han D, Deneve J, Kudchadkar R, et al
    Current and planned multicenter trials for patients with primary or metastatic melanoma.
    J Surg Oncol. 2011;104:430-7.
    PubMed     Text format     Abstract available


  52. HAMID O , Boasberg PD, Rosenthal K, O'Day SJ, et al
    Systemic treatment of metastatic melanoma: New approaches.
    J Surg Oncol. 2011;104:425-9.
    PubMed     Text format     Abstract available


  53. OLLILA DW , Gleisner AL, Hsueh EC
    Rationale for complete metastasectomy in patients with stage IV metastatic melanoma.
    J Surg Oncol. 2011;104:420-4.
    PubMed     Text format     Abstract available


  54. UREN RF , Howman-Giles R, Chung D, Thompson JF, et al
    Guidelines for lymphoscintigraphy and F18 FDG PET scans in Melanoma.
    J Surg Oncol. 2011;104:405-19.
    PubMed     Text format     Abstract available


  55. TESTORI A , Verhoef C, Kroon HM, Pennacchioli E, et al
    Treatment of melanoma metastases in a limb by isolated limb perfusion and isolated limb infusion.
    J Surg Oncol. 2011;104:397-404.
    PubMed     Text format     Abstract available


  56. TESTORI A , Faries MB, Thompson JF, Pennacchioli E, et al
    Local and intralesional therapy of in-transit melanoma metastases.
    J Surg Oncol. 2011;104:391-6.
    PubMed     Text format     Abstract available


  57. TARHINI AA , Pahuja S, Kirkwood JM
    Neoadjuvant therapy for high-risk bulky regional melanoma.
    J Surg Oncol. 2011;104:386-90.
    PubMed     Text format     Abstract available


  58. BALCH CM , Gershenwald JE, Soong SJ, Thompson JF, et al
    Update on the melanoma staging system: The importance of sentinel node staging and primary tumor mitotic rate.
    J Surg Oncol. 2011;104:379-85.
    PubMed     Text format     Abstract available


  59. WEN DR , Cochran AJ, Huang RR, Itakura E, et al
    Clinically relevant information from sentinel lymph node biopsies of melanoma patients.
    J Surg Oncol. 2011;104:369-78.
    PubMed     Text format     Abstract available


  60. LEONG SP
    Role of selective sentinel lymph node dissection in head and neck melanoma.
    J Surg Oncol. 2011;104:361-8.
    PubMed     Text format     Abstract available


  61. THOMPSON JF , Haydu LE, Sanki A, Uren RF, et al
    Ultrasound assessment of lymph nodes in the management of early-stage melanoma.
    J Surg Oncol. 2011;104:354-60.
    PubMed     Text format     Abstract available


  62. ROSS MI , Gershenwald JE
    Evidence-based treatment of early-stage melanoma.
    J Surg Oncol. 2011;104:341-53.
    PubMed     Text format     Abstract available


  63. MORTON DL
    Melanoma: Are we there yet?
    J Surg Oncol. 2011;104:337.
    PubMed     Text format    


    August 2011
  64. NAMM JP , Chang AE, Cimmino VM, Rees RS, et al
    Is a level III dissection necessary for a positive sentinel lymph node in melanoma?
    J Surg Oncol. 2011 Aug 22. doi: 10.1002/jso.22076.
    PubMed     Text format     Abstract available


  65. SHADA AL , Walters DM, Tierney SN, Slingluff CL Jr, et al
    Surgical resection for bulky or recurrent axillary metastatic melanoma.
    J Surg Oncol. 2011 Aug 8. doi: 10.1002/jso.22058.
    PubMed     Text format     Abstract available


  66. BERGER AC , Fierro M, Kairys JC, Berd D, et al
    Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
    J Surg Oncol. 2011 Aug 3. doi: 10.1002/jso.22051.
    PubMed     Text format     Abstract available


    July 2011
  67. NIEWEG OE , Veenstra HJ
    False-negative sentinel node biopsy in melanoma.
    J Surg Oncol. 2011 Jul 25. doi: 10.1002/jso.22043.
    PubMed     Text format    


  68. BOYD KU , Wehrli BM, Temple CL
    Intra-lesional interleukin-2 for the treatment of in-transit melanoma.
    J Surg Oncol. 2011 Jul 8. doi: 10.1002/jso.21968.
    PubMed     Text format     Abstract available


    June 2011
  69. TOS T , Klyver H, Drzewiecki KT
    Extensive screening for primary tumor is redundant in melanoma of unknown primary.
    J Surg Oncol. 2011 Jun 30. doi: 10.1002/jso.21994.
    PubMed     Text format     Abstract available


  70. PACE M , Gattai R, Mascitelli EM, Millanta L, et al
    Results of isolated lower limb perfusion for loco-regional advanced/recurrent melanoma using borderline true hyperthermia plus additional bolus of melphalan. A critical analysis of homogeneous cases.
    J Surg Oncol. 2011 Jun 30. doi: 10.1002/jso.21949.
    PubMed     Text format     Abstract available


    May 2011
  71. TANAKA R , Koyanagi K, Narita N, Kuo C, et al
    Prognostic molecular biomarkers for cutaneous malignant melanoma.
    J Surg Oncol. 2011 May 9. doi: 10.1002/jso.21969.
    PubMed     Text format     Abstract available


  72. VEENSTRA HJ , Wouters MJ, Kroon BB, Olmos RA, et al
    Less false-negative sentinel node procedures in melanoma patients with experience and proper collaboration.
    J Surg Oncol. 2011 May 2. doi: 10.1002/jso.21967.
    PubMed     Text format    


  73. LEONG SP , Gershenwald JE, Soong SJ, Schadendorf D, et al
    Cutaneous melanoma: A model to study cancer metastasis.
    J Surg Oncol. 2011;103:538-49.
    PubMed     Text format     Abstract available


  74. LEONG SP , Nakakura EK, Pollock R, Choti MA, et al
    Unique patterns of metastases in common and rare types of malignancy.
    J Surg Oncol. 2011;103:607-14.
    PubMed     Text format     Abstract available


  75. GHADIALLY R
    The role of stem and circulating cells in cancer metastasis.
    J Surg Oncol. 2011;103:555-7.
    PubMed     Text format     Abstract available


  76. HOON DS , Ferris R, Tanaka R, Chong KK, et al
    Molecular mechanisms of metastasis.
    J Surg Oncol. 2011;103:508-17.
    PubMed     Text format     Abstract available


    April 2011
  77. MANNAL PW , Schneider J, Tangada A, McDonald D, et al
    Honokiol produces anti-neoplastic effects on melanoma cells in vitro.
    J Surg Oncol. 2011 Apr 6. doi: 10.1002/jso.21936.
    PubMed     Text format     Abstract available


  78. NEVES RI , Reynolds BQ, Hazard SW, Saunders B, et al
    Increased post-operative complications with methylene blue versus lymphazurin in sentinel lymph node biopsies for skin cancers.
    J Surg Oncol. 2011;103:421-5.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: